1986 .03 ~ 1992 .02 서울대학교 의학 학사
1997 .09 ~ 2001 .02 고려대학교 의학 석사
2002 .03 ~ 2004 .02 성균관대학교 의학 박사

1993 .03 ~ 1994 .02 서울대학교병원 인턴
1996 .03 ~ 2000 .02 삼성서울병원 전공의
2000 .03 ~ 2002 .02 서울아산병원 전임의
2002 .03 ~ 현재 울산의대 서울아산병원 류마티스내과 교수
2006 .09 ~ 2007 .08 University of California San Diego(UCSD) 연수
2011 .03 ~ 현재 서울아산병원 류마티스내과 과장
2011 .03 ~ 2016 .12 서울아산병원 ARC 부실장
2017 .01 ~ 현재 서울아산병원 ARC 실장

Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus.
Reduction or cessation of antiviral agents in hepatitis B virus carriers treated with biologic agents.
Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database.
CD14(+) Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis.
Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study.
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.
Longterm Outcomes of Renal Artery Involvement in Takayasu Arteritis.
Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea.
Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
The Reply.
Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases.
Febuxostat in Hyperuricemic Patients With Advanced CKD.
Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes.
Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
Safety of tumor necrosis factor inhibitor therapy in patients with a prior malignancy.
Clinical outcomes of hydronephrosis in patients with systemic lupus erythematosus.
Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
Factors related to outcomes in lupus-related protein-losing enteropathy
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.
Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis
Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Pericentral hydroxychloroquine retinopathy in Korean patients.
Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay
Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises.
Lupus enteritis: clinical characteristics and predictive factors for recurrence.
Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy
Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy.
Neuro-beh?et's disease in South Korea: clinical characteristics and treatment response.
Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation.
Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.
Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors.
TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.
The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment
Clinical features and prognosis in 82 patients with adult-onset Still's disease.
Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis
Combined use of a TST and the T-SPOT?.TB assay for latent tuberculosis infection diagnosis before anti-TNF-